SCHEMBL17431908

SCHEMBL17431908

COc1cccc(OC)c1-c1ccc(-c2ccc(-c3c(OC)cccc3OC)s2)s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 4/20 0.57
▸ CA1 P00915 5/20 0.46
▸ CA2 P00918 5/20 0.46
▸ CA7 P43166 4/20 0.46
▸ CA9 Q16790 4/20 0.46
▸ CA12 O43570 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ CA4 P22748 1/20 0.46
▸ TOP1 P11387 1/20 0.42
▸ CYP3A4 P08684 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TP53 P04637 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790458 0.98 APP (0.59) APPCA1CA2CA7CA9
SCHEMBL19521918 0.87 APP (0.46) APPCA1CA2CA7CA9
SCHEMBL14225418 0.87 APP (0.46) APPCA1CA2CA7CA9
SCHEMBL14225431 0.87 APP (0.46) APPCA1CA2CA7CA9
SCHEMBL14225415 0.85 APP (0.47) APPCA1CA2CA7CA9
SCHEMBL17642062 0.79 APP (0.50) APPCA1CA2CA7CA9
SCHEMBL17431884 0.78 APP (0.38) APPCA1CA2CA7CA9
SCHEMBL14225439 0.78 APP (0.43) APPCA1CA2CA7CA9
SCHEMBL28148154 0.77 CA1 (0.65) CA1CA2CA7CA9CA12
SCHEMBL17431936 0.74 ALDH1A1 (0.45) APPALDH1A1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 — — US disclosed
US-9969931-B2 Electrochromic composition and electrochromic element CANON KABUSHIKI KAISHA (JP) 2018-05-15 — — US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 — — US disclosed
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2017-04-27 — — US disclosed
WO-2016006204-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT CANON KABUSHIKI KAISHA (JP) 2016-01-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114274-A1 ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT SCN11A, ECH1, H1-0 APP 2275/4885CA1 140/4885CA2 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback